{"id":26641,"date":"2022-11-09T15:57:55","date_gmt":"2022-11-09T14:57:55","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=26641"},"modified":"2022-11-09T16:14:40","modified_gmt":"2022-11-09T15:14:40","slug":"working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/","title":{"rendered":"Publication &#8211; Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ?"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"270\" height=\"382\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png\" alt=\"\" class=\"wp-image-26643\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png 270w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image-212x300.png 212w\" sizes=\"(max-width: 270px) 100vw, 270px\" \/><\/figure>\n\n\n\n<p><a href=\"https:\/\/www.tse-fr.eu\/people\/pierre-dubois\" target=\"_blank\" rel=\"noreferrer noopener\">Pierre Dubois<\/a>, <a href=\"https:\/\/www.tse-fr.eu\/people\/paul-henri-moisson\" target=\"_blank\" rel=\"noreferrer noopener\">Paul-Henri Moisson<\/a> &amp; <a href=\"https:\/\/www.tse-fr.eu\/people\/jean-tirole\" target=\"_blank\" rel=\"noreferrer noopener\">Jean Tirole<\/a>, \u201d<a href=\"https:\/\/www.tse-fr.eu\/sites\/default\/files\/TSE\/documents\/HealthCenter\/2022-11_transferable_patent_extensions.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Can transferable patent extensions solve the market failure for antibiotics?<\/a>\u201d, November 2022<\/p>\n\n\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>En Novembre 2022, le Journal &#8220;\u00c9conomie des antibiotiques et de l&#8217;antibior\u00e9sistance&#8221; de la Toulouse School of Economics analyse le <em>Position paper &#8221; The Economics of Transferable Patent Extensions&#8221;<\/em> \u00e9crit par Jean Tirole, Pierre Dubois et Paul-Henri Moisson sur le mod\u00e8le des \u00ab\u00a0vouchers\u00a0\u00bb (extension de droits de propri\u00e9t\u00e9 intellectuelle cessibles) comme m\u00e9canisme incitatif \u00e0 l\u2019innovation dans le domaine de l&#8217;antibior\u00e9sistance. <\/p>\n\n\n\n<p>Ce syst\u00e8me  fournit en effet une &#8221; monnaie &#8221; originale pour r\u00e9compenser les inventeurs : L&#8217;inventeur d&#8217;un m\u00e9dicament innovant se verrait octroyer un droit d&#8217;extension de brevet, et ce droit pourrait \u00eatre vendu \u00e0 une entit\u00e9 disposant d&#8217;un droit de Propri\u00e9t\u00e9 Intellectuelle, qui b\u00e9n\u00e9ficierait alors d&#8217;une p\u00e9riode d&#8217;exclusivit\u00e9 suppl\u00e9mentaire apr\u00e8s la date d&#8217;expiration normale de protection du brevet.<\/p>\n\n\n\n<div style=\"height:34px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<ul><li><a href=\"https:\/\/www.tse-fr.eu\/sites\/default\/files\/TSE\/documents\/HealthCenter\/2022-11_transferable_patent_extensions.pdf\">Acc\u00e8s au journal<\/a><\/li><li><a href=\"https:\/\/www.tse-fr.eu\/sites\/default\/files\/TSE\/documents\/doc\/wp\/2022\/wp_tse_1377.pdf\">Acc\u00e8s au<em> Position paper<\/em><\/a><\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Pierre Dubois, Paul-Henri Moisson &amp; Jean Tirole, \u201dCan transferable patent extensions solve the market failure for antibiotics?\u201d, November 2022 En Novembre 2022, le Journal &#8220;\u00c9conomie des antibiotiques et de l&#8217;antibior\u00e9sistance&#8221; de la Toulouse School of Economics analyse le Position paper &#8221; The Economics of Transferable Patent Extensions&#8221; \u00e9crit par Jean Tirole, Pierre Dubois et Paul-Henri [&hellip;]<\/p>\n","protected":false},"author":271,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Publication - Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ? - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Le Journal &quot;\u00c9conomie des antibiotiques et de l&#039;antibior\u00e9sistance&quot; de la Toulouse School of Economics traite en Novembre 2022 du Position paper \u00e9crit par Jean Tirole et Pierre Dubois &quot;The Economics of Transferable Patent Extensions&quot;.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Publication - Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ? - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Le Journal &quot;\u00c9conomie des antibiotiques et de l&#039;antibior\u00e9sistance&quot; de la Toulouse School of Economics traite en Novembre 2022 du Position paper \u00e9crit par Jean Tirole et Pierre Dubois &quot;The Economics of Transferable Patent Extensions&quot;.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-09T14:57:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-09T15:14:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png\" \/>\n<meta name=\"author\" content=\"Loane Serrano\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Loane Serrano\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/\"},\"author\":{\"name\":\"Loane Serrano\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61\"},\"headline\":\"Publication &#8211; Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ?\",\"datePublished\":\"2022-11-09T14:57:55+00:00\",\"dateModified\":\"2022-11-09T15:14:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/\"},\"wordCount\":170,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/\",\"name\":\"Publication - Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ? - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png\",\"datePublished\":\"2022-11-09T14:57:55+00:00\",\"dateModified\":\"2022-11-09T15:14:40+00:00\",\"description\":\"Le Journal \\\"\u00c9conomie des antibiotiques et de l'antibior\u00e9sistance\\\" de la Toulouse School of Economics traite en Novembre 2022 du Position paper \u00e9crit par Jean Tirole et Pierre Dubois \\\"The Economics of Transferable Patent Extensions\\\".\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Publication \u2013 Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61\",\"name\":\"Loane Serrano\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Publication - Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ? - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Le Journal \"\u00c9conomie des antibiotiques et de l'antibior\u00e9sistance\" de la Toulouse School of Economics traite en Novembre 2022 du Position paper \u00e9crit par Jean Tirole et Pierre Dubois \"The Economics of Transferable Patent Extensions\".","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/","og_locale":"en_GB","og_type":"article","og_title":"Publication - Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ? - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Le Journal \"\u00c9conomie des antibiotiques et de l'antibior\u00e9sistance\" de la Toulouse School of Economics traite en Novembre 2022 du Position paper \u00e9crit par Jean Tirole et Pierre Dubois \"The Economics of Transferable Patent Extensions\".","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2022-11-09T14:57:55+00:00","article_modified_time":"2022-11-09T15:14:40+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png"}],"author":"Loane Serrano","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Loane Serrano","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/"},"author":{"name":"Loane Serrano","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61"},"headline":"Publication &#8211; Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ?","datePublished":"2022-11-09T14:57:55+00:00","dateModified":"2022-11-09T15:14:40+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/"},"wordCount":170,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/","name":"Publication - Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ? - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png","datePublished":"2022-11-09T14:57:55+00:00","dateModified":"2022-11-09T15:14:40+00:00","description":"Le Journal \"\u00c9conomie des antibiotiques et de l'antibior\u00e9sistance\" de la Toulouse School of Economics traite en Novembre 2022 du Position paper \u00e9crit par Jean Tirole et Pierre Dubois \"The Economics of Transferable Patent Extensions\".","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/11\/image.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/working-papers-can-transferable-patent-extensions-solve-the-market-failure-for-antibiotics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"Publication \u2013 Les extensions de brevets transf\u00e9rables peuvent-elles r\u00e9soudre la d\u00e9faillance du march\u00e9 des antibiotiques ?"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61","name":"Loane Serrano"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-17 10:40:47","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/26641"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/271"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=26641"}],"version-history":[{"count":7,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/26641\/revisions"}],"predecessor-version":[{"id":26659,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/26641\/revisions\/26659"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=26641"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=26641"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=26641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}